Rights and permissions
About this article
Cite this article
Berlex has launched its oral contraceptive ethinylestradiol/drospirenone [`Yasmin'] in the US,. Inpharma Wkly. 1296, 18 (2001). https://doi.org/10.2165/00128413-200112960-00034
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200112960-00034